Medical management of postoperative recurrence in Crohn's disease
Authors:
- 1 June 2004
- journal article
- review article
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 33 (2) , 347-360
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn's disease: A randomized controlled study VS mesalamineGastroenterology, 2000
- Prevention of post‐operative recurrence of Crohn’s disease requires adequate mucosal concentration of mesalazineAlimentary Pharmacology & Therapeutics, 1999
- Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitisGastroenterology, 1999
- A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study GroupGastroenterology, 1997
- Duration of recurrent ileitis after ileocolonic resection correlates with presurgical extent of Crohn's disease.Gut, 1995
- Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's diseaseGastroenterology, 1995
- Analysis of clinical course of postoperative recurrence in Crohn's Disease of distal ileumDigestive Diseases and Sciences, 1992
- Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileumThe Lancet, 1991
- The Long-term Prophylactic Effect of Salazosulfapyridine (SalazopyrinR) in Primarily Resected Patients with Crohn's DiseaseScandinavian Journal of Gastroenterology, 1978
- The early and late results of surgical treatment for Crohn's diseaseBritish Journal of Surgery, 1971